correlation between changes in OH and ECW, there was none for weight. Our findings do not support total reliance on pre-dialysis BIS alone for assessing volume status in HD patients, but rather BIS should be considered an aid to clinical assessment of volume status.
Introduction
Despite the success of haemodialysis (HD), with >2 million patients now treated worldwide, the mortality of HD patients remains high and is greater than that for some of the more common solid organ malignancies. Most deaths are cardiovascular in nature, with an increased risk of sudden deaths thought to be due to dysrhythmias. For patients dialysing thrice weekly, more HD patients are admitted to hospital or experience sudden death in the hours before the first dialysis session of the week [1] , when they mostly experience volume overload. As such, achieving a target weight when patients are no longer volume expanded by achieving a normal extracellular water (ECW) volume has been reported to improve patient survival [2] .
Bioimpedance devices estimate the amount of fluid in the body by measuring the electrical resistance to a series
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Bioimpedance · Haemodialysis · Hydration total body water · Extracellular water · Intracellular water Abstract Introduction: Bioelectrical impedance spectroscopy (BIS) devices are being used to determine ultrafiltration requirements to achieve target weight for haemodialysis (HD) patients. Pre-dialysis measurements are more convenient for both patients and staff. We wished to compare the changes in pre-and post-dialysis hydration measured by BIS with actual weight loss. Methods: We compared paired BIS measurements made pre and post HD using a BIS device based on a 3-compartmental model, designed to provide information on extracellular water (ECW) excess. Results: BIS was measured in 49 HD patients, 35 male (71.4%) with mean age 67.6 ± 14.2. Weight fell significantly from 69.2 ± 17.8 to 67.6 ± 17.4 kg, and BIS over hydration (OH) from 4.5 ± 3.3.4 to 3.4 ± 2.9 litres, and ECW from 16.8 ± 4.8 to 15.5 ± 4.4 litres, but there was no change in the amount of intracellular water. Weight loss correlated positively with the change in ECW, but exceeded the fall in OH; mean bias -0.58 (95% confidence limits -3.6 to 4.8 kg). Summary: We measured OH pre and post HD, but did not find that the change in OH correlated with changes in body weight. Although there was a of alternating currents flowing between electrodes placed on the hand and foot [3, 4] . There are a number of bioimpedance devices commercially available that have varying number of electrical frequencies to measure body segments or total body [5, 6] . Bioelectrical impedance spectroscopy (BIS) assessments of total body water (TBW), ECW and intracellular water (ICW) have been validated against 'gold standard' isotopic methods [7] . In everyday clinical practice, BIS measurements are made pre HD to determine ultrafiltration requirements to achieve a normally hydrated status, or target weight post dialysis. Most bioimpedance devices have used a similar model to dual energy X-ray absorptiometry scanning, in terms of dividing the body into 2 basic compartments; fat mass and fat-free mass, from which ICW and ECW are derived. However, for the dialysis patient, it has been difficult to express the amount of excess fluid (over hydration (OH)) that a dialysis patient needs to lose to restore euvolaemia using this approach, with studies reporting ratios of ECW/TBW [8] , or using equations to estimate ECW excess based on a normal ratio of ECW to ICW [9] . Newer BIS devices are now available, expressing OH, by using a 3-body compartmental approach, dividing the lean body mass into normally hydrated tissue and the excess fluid as OH [3, 7] .
The assumption is that OH measured pre dialysis provides information to guide the clinical team as to how much fluid should be during the dialysis session to return the patient to their target or post-dialysis weight. We therefore reviewed, pre-and post-dialysis bioimpedance measurements [10] , to determine whether change in OH corresponded to the change in body weight following dialysis, to determine whether pre-dialysis measurement of OH by bioimpedance could be used to guide intra-dialytic weight loss.
Methods
We audited the results of pre-and post-HD BIS measurements (BodyStat Multiscan 5000, Douglas, Isle of Man). All HD sessions were performed with patients lying on a bed, and using Fresenius 4000H dialysis machines (Fresenius MC, Bad Homburg, Germany), with a high-flux dialyzer (Elisio, Nipro Corporation, Osaka, Japan) [11] anticoagulated with low molecular weight heparin (tinzaparin, Leo Laboratories, Princes Risborough, UK) [12] , using ultrapure quality dialysis water. Dialysis machines were regularly serviced and dialysate sodium checked [13] . Dialysate bicarbonate was fixed at 32 mmol/l, with 3.0 mmol/l of acetate and 0.5 mmol/l of magnesium . Serum chemistries were measured prior to dialysis with a standard laboratory analyser (Roche Cobra II, Basingstoke, UK), by a UK accredited laboratory.
The amount of fluid to be removed during the dialysis session was determined by the clinical team, and if required, ultrafiltration was set at a constant rate. Patients were restricted to one small drink during the dialysis session (approximately 180 ml) and no food was given.
Bioimpedance measurements were made with the patient lying in bed. Four electrodes were placed according to the manufacturer's instructions on the contra-lateral hand and wrist, ankle and dorsum of the foot to the arterio-venous fistula. Electrodes remained in position for the course of the dialysis session, and for post-dialysis measurements. The BIS device measures whole body resistance and reactance with 50 different alternating electrical current frequencies ranging from 5 to 1,000 kHz. Due to different amounts of water in body tissues, the BIS device computes ECW and ICW as well as ECW excess as OH (litres) from an estimation of normo-hydrated tissues.
To allow time for re-equilibration, post-dialysis measurements were made after the fistula needle sites had stopped bleeding, patients had been re-weighed using the same scales, returned to bed and then rested. To ensure that patients were at a stable state, we repeated measurements up to 4 times in a number of patients.
Statistical Methods
Statistical analysis was performed by parametric or non-parametric pair testing, analysis of variance (ANOVA) with appropriate post hoc testing, and univariate correlation, using Pearson or Spearman correlation (Prism 6.0, Graph Pad, San Diego, Calif., USA), and Bland-Altman analysis (version 3.0; Analyse It, Leeds, UK), with significance at the p < 0.05 level. Data is reported as mean ± SD, median and interquartile range or percentage.
Ethics
Standard clinical practice in our centre is to measure bioimpedance pre and post dialysis, as standard equipment uses a 2-compartmental model. We audited the results of pre-and post-HD BIS measurements made with bioimpedance device using a 3-compartmental model in consecutive patients to determine whether bioimpedance-derived body composition should be measured pre or post dialysis to be the standard of care for routine clinical practice.
Results
Pre-and corresponding post-BIS measurements were retrospectively reviewed in 49 consecutive adult patients receiving in-centre HD session who had corresponding pre-and post-dialysis session BIS measurements, 35 male (71.4%), mean age 67.6 ± 14.9 years, 22 Caucasoid (44.9%), 14 South Asian (28.6%), 7 African-Afro-Caribbean (14.3%) and 6 Far Asian (12.2%). Twenty-two patients were diabetic (44.9%), and the median Davies co-morbidity score [14] was 2 (1-3). Pre-dialysis haemoglobin was 103.4 ± 19.1 g/l, serum albumin 36.4 ± 4.8 g/l, potassium 4.3 ± 0.9 mmol/l, urea 18.4 ± 6.2 mmol/l, calcium 2.32 ± 0.14 mmol/l, C-reactive protein 8 (4-28) mg/l.
Median dialysate sodium was 137 (136-138.5 mmol/l, potassium 2.0 (1-2) mmol/l, with a calcium 1.35 (1.0-1.35) mmol/l. Dialysate was cooled, median temperature 35.0 (35.0-35.5) ° C. The median dialyzer surface area was 2.1 (1.7-2.1) m 2 . To ensure that patients were in a stable state when post-dialysis BIS measurements were made, 3 sets of measurements were made after 38 of the dialysis sessions. There was no significant change by ANOVA in the measurement of OH, ICW or ECW over time ( table 1 ) . In 12 patients, 4 separate measurements were made post dialysis, to determine whether there was any change over time, and there were no differences noted between measurements (1st measurement ECW 17.0 ± 4.6 vs. 4th measurement 17.0 ± 4.6 litres; and ICW 17.0 ± 5.6 vs. 17.0 ± 5.4 litres, respectively).
Clinician notes of clinical volume assessments made prior to dialysis were reviewed and the patients assigned into 4 groups: dehydrated with no overt clinical signs of ECW excess, pitting ankle oedema or elevated jugular venous pulsation, or gross ECW excess and clinical heart failure. OH measurements increased sequentially in these 4 groups from 3.05 ± 0.07 (n = 2), to 3.97 ± 3.69 (n = 16), 4.29 ± 2.8 (n = 23) and finally 6.7 ± 2.56 kg (n = 8), in keeping with the clinical assessment of increasing fluid retention. As there were so few patients thought clinically to be dehydrated, we compared the group clinically thought to be euvolaemic and those with signs of ECW excess. As clinical assessment of ECW excess increased, then so did OH measured by BIS, p < 0.05 by ANOVA testing. Prior to dialysis there was a correlation between OH and ECW (r = 0.69, p < 0.001) but not TBW (r = 0.25, p = 0.062) or ICW (r = -0.13, p = 0.34).
We compared the paired pre-and post-dialysis BIS measurements for each session, and as expected weight, and BIS measurements of TBW, ECW and OH fell significantly post dialysis ( table 2 ) . There was a simple correlation between the change in weight following dialysis with the change in TBW (r = 0.55, p = 0.03). We then compared the change in weight and TBW by Bland-Altman analysis, which showed that the change in weight was greater than that in TBW, mean bias -0.03 (95% limit of agreement -8.2 to 8.1 litre/kg; fig. 1 ). However, there was no significant correlation between the change in pre-and post-dialysis weight and OH (r = -0.10, p = 0.51).
We then compared the change in patient weight and OH by Bland-Altman analysis ( fig. 2 ) . Again, the difference in weight was greater than that for OH following dialysis, mean bias 0.58 (95% limits of agreement -3.6 to 4.8. The change in weight with dialysis correlated with the change in ECW (r = 0.44, p < 0.01), but not with ICW (r = -0.18, p = 0.70). The change in OH was positively associated with a change in ECW (r = 0.31, p = 0.03), and ratio of ECW/TBW (r = 0.84, p < 0.001; fig. 3 ). Values expressed as mean ± SD. Values expressed as mean ± SD. To consider other factors that may have affected the change in ECW, we considered body size, in terms of weight and BMI. However, there was no statistical association between body size pre dialysis and the change in OH or change in the ratio of OH/ECW. Similarly, there was no association with age, gender, diabetes or co-morbidity score. We did, however, find an association between the change in OH with the difference between predialysis serum sodium and the dialysate sodium concentration t (r = 0.43, p = 0.02) and negatively with CRP (r = -0.45, p < 0.01). We also noted an association between pre-dialysis serum sodium and dialysate sodium gradient and the change in ECW (r = 0.73, p < 0.001) but not with ICW.
Discussion
One of the goals of HD treatment is to correct volume overload and return patients to their target weight, as most of these patients would be expected to lose weight, with corresponding reductions in TBW, ECW and ICW [15] . We measured BIS pre-and post-dialysis sessions and compared the results from consecutive patients. A clinical decision was made in each case to determine the ultrafiltration target. We found a step-wise increase in the mean pre-dialysis assessment of volume status made by BIS and clinical assessment of volume status, and there was a positive correlation between pre-dialysis OH and ECW volume.
We chose to measure weight loss, rather than ultrafiltration rates or ultrafiltration measured by the dialysis machine to exclude errors in calculating volume loss due to fluid changes with connecting patients to the dialysis machine and differences in wash back at the end of the dialysis session. As expected, following dialysis there was a reduction in weight for the cohort. The weight loss was greater than both the change in TBW and OH. This is to be expected as normal plasma water has a higher density than water, and that from dialysis patients even greater due to the effects of urea and other azotaemic retention solutes. As such, 1 litre of ultrafiltrate weighs >1.0 kg. However, in calculating OH, it was assumed that 1 litre of OH was equivalent to 1 litre of water (1.0 kg) [3] . Although there was a correlation between the change in weight following dialysis and both ECW and TBW, there was no statistical association with change in ICW. Other reports have noted that changes in skin temperature due to differences in local blood flow lead to changes in bioimpedance measurements, with cooling and vasoconstriction resulting in an increase in impedance, whereas vasodilatation reduced impedance [16] . However, the algorithm used by the BIS is based on determining OH as being the amount of ECW excess for normally hydrated tissues, and as such, ICW using this model would not be expected to change post dialysis. However, a recent study reported removing sodium from tissues during dialysis [17] , and as such, this would be expected to cause changes in ICW. Previous reports have suggested that using lower dialysate sodium can lead to a greater reduction in ECW [18] , and we also noted an association between the serum to dialysate sodium gradient with both the change in OH and ECW.
Our results, demonstrate that the majority of change in OH is due to a change in ECW, which supports a previous report of using BIS and a 3-compartmental body composition model [19, 20] . As such, pre-dialysis measurements of OH have been used to aid clinical decision making in terms of the amount of ultrafiltration required to return patients to a normo-volaemic state [21] . Most studies have only reported pre-dialysis measurements [20, 22] , and there has been an assumption that the predialysis OH measurement was correct. However, our data, although showing an increasing OH with clinical assessment of volume status, suggests that the actual measurement of OH pre dialysis should be used in conjunction with clinical assessment of volume status, and not replace clinical judgement.
Previous studies on BIS have reported on Caucasoid and African-American HD patients [2, 3, 22] , and we did have patients from other ethnic groups, and reports have suggested that some bioimpedance measurements may vary between ethnic groups, but not in terms of ECW status [23, 24] , and we also did not find any association with ethnicity.
In theory, post-dialysis bioimpedance measurements could be affected by the electrolyte shifts occurring during the session [25] . This effect has been thought to be of minimal clinical relevance by some groups [3] , whereas others have suggested that the change in resistivity during the course of a HD session could potentially lead to an ECW change of around -3.2 to 1.4% and -3.7 to 1.7% for ICW. This would potentially introduce an error in estimating ICW of 20% or more, and a lower ECW error of <15% [25] . We did note an effect of CRP and the change in OH with dialysis.
Inflammatory conditions can lead to increased capillary permeability and ECW expansion [26] , and as such, this may affect the amount of fluid which can be readily removed during a dialysis session, in keeping with a negative association between CRP and change in OH.
We allowed time for changes in blood flow and electrolyte shifts to re-equilibrate at the end of the dialysis session [27] , and also the potential effect of a change in posture [28] , so that when we repeated up to 4 measurements post HD, we found no significant differences. Unlike with some other BIS devices, the electrodes remained in place during the dialysis session [29] , and no electrode had to be replaced, thereby eliminating error due to changes in electrode position.
Our retrospective audit has several limitations. There were a number of outlying data points for the change in TBW: 1 patient was thought to be dehydrated pre dialysis and had an increased in weight with dialysis, and conversely another patient was thought to be markedly overhydrated and had a large weight loss following dialysis. As this was an audit and not a study, we do not have any comparative measurements of body volume by isotopic methods, or bioimpedance equipment, using a standard 2-body compartment model [4] .
Compared to standard bioimpedance devices [30] , we have compared pre-and post-HD measurements with a BIS device using a 3-body compartmental model determining fluid overload. Although there was a trend between the clinical assessment of fluid overload and the OH measured by bioimpedance, this was not significant. We observed that the change in patient weight did not correlate with the measured changes in OH, or ICW. Weight change was predominantly related to changes in ECW. Previous studies targeting weight loss according to pre-dialysis BIS measurements have reported premature loss of residual renal function [31] . As such, we would suggest that pre-dialysis BIS determination of OH should be used in conjunction with clinical assessments of volume status, and not replace clinical judgement, particularly for patients with evidence of systemic inflammation.
